Cargando…
Monitoring HSP70 exosomes in cancer patients’ follow up: a clinical prospective pilot study
Exosomes are nanovesicles released by all cells that can be found in the blood. A key point for their use as potential biomarkers in cancer is to differentiate tumour-derived exosomes from other circulating nanovesicles. Heat shock protein-70 (HSP70) has been shown to be abundantly expressed by canc...
Autores principales: | Chanteloup, Gaëtan, Cordonnier, Marine, Isambert, Nicolas, Bertaut, Aurélie, Hervieu, Alice, Hennequin, Audrey, Luu, Maxime, Zanetta, Sylvie, Coudert, Bruno, Bengrine, Leila, Desmoulins, Isabelle, Favier, Laure, Lagrange, Aurélie, Pages, Pierre-Benoit, Gutierrez, Ivan, Lherminier, Jeanine, Avoscan, Laure, Jankowski, Clémentine, Rébé, Cédric, Chevriaux, Angélique, Padeano, Marie-Martine, Coutant, Charles, Ladoire, Sylvain, Causeret, Sylvain, Arnould, Laurent, Charon-Barra, Céline, Cottet, Vanessa, Blanc, Julie, Binquet, Christine, Bardou, Marc, Garrido, Carmen, Gobbo, Jessica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7301715/ https://www.ncbi.nlm.nih.gov/pubmed/32595915 http://dx.doi.org/10.1080/20013078.2020.1766192 |
Ejemplares similares
-
Fluorouracil and bevacizumab plus anakinra for patients with metastatic colorectal cancer refractory to standard therapies (IRAFU): a single-arm phase 2 study
por: Isambert, Nicolas, et al.
Publicado: (2018) -
Seroprevalence of SARS-CoV-2 among the staff and patients of a French cancer centre after first lockdown: The canSEROcov study
por: Ladoire, Sylvain, et al.
Publicado: (2021) -
Parallel evolution and differences in seroprevalence of SARS-CoV-2 antibody between patients with cancer and health care workers in a tertiary cancer centre during the first and second wave of COVID-19 pandemic: canSEROcov-II cross-sectional study
por: Ladoire, Sylvain, et al.
Publicado: (2022) -
Does mammogram attendance influence participation in cervical and colorectal cancer screening? A prospective study among 1856 French women
por: Bertaut, Aurélie, et al.
Publicado: (2018) -
Anticipating changes in the HER2 status of breast tumours with disease progression—towards better treatment decisions in the new era of HER2-low breast cancers
por: Bergeron, Anthony, et al.
Publicado: (2023)